Overview

Tech Summary

Promoter Holding

Posts

ZYDUSWELL

10123456789,401234567894012345678990123456789.8012345678900123456789
+4.35 (+0.30%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 1445.45
1D
5D
1M
3M
1Y
5Y
Today's low
1440
Today's high
1452
52 week low
1370.1
52 week high
2020.15
Volume
6547
About
Tech Summary
DMA(12)
₹1584.69
DMA(50)
₹1660.86
DMA(100)
₹1639.3
DMA(200)
₹1603.57
Fund Summary
Market Cap
₹9220.73 Cr.
Enterprise Value
₹9517.92 Cr.
No. of Shares
6.36
P/E
29.87
RoE
2.96
Debt/Equity
0.12
Valuations
PE Chart
0200400600800
PB Chart
1.902.002.102.202.30
Promoter Holdings
Public : 7.51%
FII : 2.56%
DII : 25.11%
Promoter : 64.82%
Others : 0%
Charts
Debt/Equity
0.100.200.300.40
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
510152025
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
0.51.01.52.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
1015202530
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
89% Bullish
11% Bearish
9 live trades of Rs. 960,400.4
I
irfanansari-H1acgrhss
 
Reputation: 0 • 
Just now
ZYDUSWELL
500 Qty (S) Target achieved₹0
V
vasumakadia
 
Reputation: 0 • 
Just now
ZYDUSWELL
5 Qty (S) Target achieved₹33
Posts by FrontPage Users
NewsBot-display-image
Reputation: 30,555  •  Yesterday 11:43 PM
Buy Zydus Wellness; target of Rs 2000: ICICI Direct
Buy Zydus Wellness; target of Rs 2000: ICICI Direct
ICICI Direct is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 2000 in its research report dated February 03, 2023.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Feb 5 9:08 PM
Buy Zydus Wellness; target of Rs 1740: Sharekhan
Buy Zydus Wellness; target of Rs 1740: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1740 in its research report dated February 02, 2023.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Feb 3 7:01 PM
Zydus Lifesciences Q3 Results: Firm beats profit view on strong sales
Zydus Lifesciences Q3 Results: Firm beats profit view on strong sales
The impact of price hikes to mitigate inflationary pressure would be reflected from the fourth quarter onwards in the consumer wellness segment, which accounted for 10% of total revenues in the third quarter, the company said in an exchange filing.
The Economic Times
Like
Comment
Share
Add a comment
Add a comment
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jan 11 2:41 PM
Stocks to buy or sell today: 6 short-term trading ideas by experts for 11 January 2023
Stocks to buy or sell today: 6 short-term trading ideas by experts for 11 January 2023
“Options data suggests a shift in the trading range in between 17600 to 18300 zones while an immediate trading range in between 17700 to 18200 zones,” Chandan Taparia, Analyst-Derivatives at Motilal Oswal Financial Services Limited, said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jan 5 8:16 PM
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla
“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near term, there are multiple assets waiting to play out. For Cipla this year, we are hoping to see generic Advair, generic Abraxane which is most likely in the price but beyond that, there will be a generic Qvar, there will be a generic Teriparatide and potentially a generic Flovent as well.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Nov 18, 2022 5:33 AM
Buy Zydus Wellness; target of Rs 2100: ICICI Direct
Buy Zydus Wellness; target of Rs 2100: ICICI Direct
ICICI Direct is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 2100 in its research report dated November 11, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Nov 11, 2022 4:21 PM
Buy Zydus Wellness, target price Rs 2000:  ICICI Securities
Buy Zydus Wellness, target price Rs 2000: ICICI Securities
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10414.04 Crore) operating in FMCG sector.
The Economic Times
Like
Comment
Share
Add a comment
Vv Stock Zone-display-image
Reputation: 56  •  Oct 31, 2022 8:48 PM

#zyduswell bought at 1755 with sl 1690
DCB
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Oct 13, 2022 12:58 PM
Hot Stocks | Sun TV Network, Zydus Wellness can give up to 11% return in short term, here's why
Hot Stocks | Sun TV Network, Zydus Wellness can give up to 11% return in short term, here's why
Zydus Wellness has recently given a triangle pattern breakout near its long term support area on the weekly timeframe. The 200 EMA is at Rs 1,680 and the stock is comfortably sustaining above it, which can be used as a confluence to the bullish view.
Moneycontrol
Like
Comment
Share
Add a comment
HDoverseasmarket-display-image
Reputation: 2,639  •  Sep 28, 2022 1:35 AM

ZYDUS WELLNESS LTD 1 DAY DOUBLE TOP CHART
Chartbusters - chart - 13096890
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Sep 26, 2022 8:38 PM
Buy Zydus Wellness; target of Rs 2140: Anand Rathi
Buy Zydus Wellness; target of Rs 2140: Anand Rathi
Anand Rathi is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2140 in its research report dated September 23, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Sep 26, 2022 3:41 PM
Buy Zydus Wellness, target price Rs 2000:  ICICI Securities
Buy Zydus Wellness, target price Rs 2000: ICICI Securities
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10110.19 Crore) operating in FMCG sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Sep 19, 2022 4:06 PM
Buy Zydus Wellness, target price Rs 2000:  ICICI Securities
Buy Zydus Wellness, target price Rs 2000: ICICI Securities
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10416.58 Crore) operating in FMCG sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Sep 2, 2022 11:56 PM
Zydus Lifesciences, Lupin recall products in US market owing to manufacturing issues
Zydus Lifesciences, Lupin recall products in US market owing to manufacturing issues
Zydus initiated the Class II voluntary recall on July 15 this year. Similarly, Baltimore-based Lupin Pharmaceuticals, Inc, is recalling 7,872 bottles of Rifampin Capsules, a medication used to treat infections caused by bacteria.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Aug 26, 2022 5:46 AM
Bayer launches pill to treat chronic kidney disease linked to diabetes
Bayer launches pill to treat chronic kidney disease linked to diabetes
The drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Aug 25, 2022 6:41 PM
Bayer introduces medication for chronic kidney disease
Bayer introduces medication for chronic kidney disease
"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. Despite therapy, these patients often progress to kidney failure.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Aug 18, 2022 5:56 PM
Anil Matai, Vijender Singh join Jashvik Capital
Anil Matai, Vijender Singh join Jashvik Capital
Vijender Singh was most recently CEO of Metropolis Healthcare and COO of Dr. Lals Pathlabs, where Vijender helped scale both these companies under private equity ownership.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Aug 18, 2022 3:21 PM
Stocks to buy today: 10 short-term trading ideas by experts for 18 August
Stocks to buy today: 10 short-term trading ideas by experts for 18 August
Sectorally, buying was seen in realty, utilities, power, consumer discretionary, and consumer durables while selling was visible in healthcare, IT, oil & gas, and energy stocks.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Aug 2, 2022 9:28 PM
Buy Zydus Wellness; target of Rs 2100: ICICI Direct
Buy Zydus Wellness; target of Rs 2100: ICICI Direct
ICICI Direct is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2100 in its research report dated July 31, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jul 31, 2022 8:28 PM
Buy Zydus Wellness; target of Rs 2250: Sharekhan
Buy Zydus Wellness; target of Rs 2250: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated July 29, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
Revanth Nifty Radar-display-image
Reputation: 15,448  •  Jul 29, 2022 6:36 PM

#ZYDUSWELL reports Q1 earnings.

▶️ Cons Net Profit up 4.7% at ₹137 cr Vs ₹131 cr (YoY)

▶️ Cons Revenue up 16.6% at ₹696 cr Vs ₹597 cr (YoY)

▶️ Cons EBITDA up 5.4% at ₹147.4 cr Vs ₹140 cr (YoY)

▶️ EBITDA margin at 21.2% Vs 23.4% (YoY)
ZYDUSWELL - 11106219
1 Like
Comment
Share
Add a comment
Revanth Nifty Radar-display-image
Reputation: 15,448  •  Jul 13, 2022 5:05 PM

#ZYDUSWELL : RS 151.98CR NSE BLOCK TRADE; FOR ~986897 SHARES, AT RS 1540
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jul 7, 2022 12:56 AM
Zydus Wellness proactively looking for acquisitions; to enter new overseas markets
Zydus Wellness proactively looking for acquisitions; to enter new overseas markets
"The company is confident to drive growth and increase the market share of its brands through innovation, leveraging distribution channels and expanding the brand portfolio," said Zydus Wellness.
The Economic Times
Like
Comment
Share
Add a comment
M
Reputation: 1,144  •  Jul 1, 2022 2:29 PM

POSITIONAL LOOKS GOOD
ZYDUS WELLNESS
CMP. 1636
SUPPORT. 1550
RESISTANCE OPEN
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jun 25, 2022 12:46 PM
Snacks, stationery sales pick up as kids return to school
Snacks, stationery sales pick up as kids return to school
Physical reopening of educational institutions has thrown a lifeline to categories such as stationeries and school shoes that were hit hard by Covid-19 and study from home, while impulse categories like packaged snacks and confectionery have got a boost amid an overall slowdown in discretionary spending.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Jun 9, 2022 7:26 PM
O4S launches new business podcast series featuring industry leaders
O4S launches new business podcast series featuring industry leaders
Each episode is an exclusive interview, which is available on O4S Labs, the companys YouTube channel.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  May 19, 2022 3:03 AM
Buy Zydus Wellness: target of Rs 2250: Sharekhan
Buy Zydus Wellness: target of Rs 2250: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 17, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
BankNifty Expert-display-image
Reputation: 49,969  •  May 17, 2022 10:39 PM

Zydus Wellness March 2022 (Quarterly) PAT at Rs 133 crore VS Rs 133crore YoY Revenue at Rs 640 crore VS Rs 606 crore YoY
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  May 16, 2022 12:30 AM

#ZYDUSWELL will declare results on May 17, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  May 11, 2022 6:36 AM
As rupee falls and input costs rise, companies weigh further price hikes
As rupee falls and input costs rise, companies weigh further price hikes
Executives said they may have to push the next round of price hike as early as this month itself despite the last price hike undertaken in end-March or April with the falling rupee impacting their immediate consignment of goods coming into the country.
The Economic Times
Like
Comment
Share
Add a comment
Know Your Stocks-display-image
Reputation: 2,415  •  May 2, 2022 2:45 PM
3 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Apr 12, 2022 10:18 PM
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
Net Sales are expected to increase by 12.8 percent Y-o-Y (up 76 percent Q-o-Q) to Rs. 683.2 crore, according to ICICI Direct.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Apr 4, 2022 4:28 PM
Buy Zydus Wellness: target of Rs 2250: ICICI Securities
Buy Zydus Wellness: target of Rs 2250: ICICI Securities
ICICI Securities is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 2250 in its research report dated April 02, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
Equity And Option Trader-display-image
Reputation: 49,180  •  Apr 1, 2022 10:51 PM
NIKHILMAHESHWARI in ZYDUSWELL
#ZYDUSWELL looking rock solid. Need a push abov...

#ZYDUSWELL High of 1565. LTP 1559.60.
Expecting more.
Like
Comment
Share
Add a comment
Equity And Option Trader-display-image
Reputation: 49,180  •  Apr 1, 2022 7:20 PM

#ZYDUSWELL looking rock solid. Need a push above 1555.
Like
Comment
Share
Add a comment
AkTrader-display-image
Reputation: 1,824  •  Apr 1, 2022 5:07 PM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Mar 28, 2022 11:11 PM
Emami 'Dermicool' buyout no game changer but up to 56% upside likely
Emami 'Dermicool' buyout no game changer but up to 56% upside likely
Emami has historically used an inorganic route to growth including the acquisition of Zandu (2009), Kesh King (2015) and German brand Creme 21 (2019). These brands or businesses have over the years emerged as major brands for the company.
The Economic Times
Like
Comment
Share
Add a comment
Gyanee-display-image
Reputation: 9,054  •  Mar 24, 2022 2:57 AM
Like
Comment
Share
Add a comment
Equitymarket ಕನ್ನಡ  -display-image
Reputation: 750  •  Mar 17, 2022 5:18 PM
1 Like
Comment
Share
Add a comment
RG finpati-display-image
Reputation: 3,660  •  Feb 23, 2022 3:25 AM


Zydus Wellness:

CMP 1525
Add more if it comes to 1140

SL below 960 on Weekly Closing basis

Target 3500
Expected Time frame 2025

Disclaimer: I am not SEBI registered Analyst, nor intend to be one. The above is just for education purposes. Please do your analysis b......read more
Chartbusters - chart - 7745045
1 Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Feb 1, 2022 12:30 AM

#ZYDUSWELL will declare results on Feb 2, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 30,555  •  Nov 24, 2021 12:51 PM
Zydus shot to soon join other vaccines in India's Covid fight
Zydus shot to soon join other vaccines in India's Covid fight
The drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can be given to people 12 years and above.
The Economic Times
Like
Comment
Share
Add a comment
Load More Posts